167 related articles for article (PubMed ID: 8642670)
1. E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation.
Sparkowski J; Mense M; Anders J; Schlegel R
J Virol; 1996 Apr; 70(4):2420-30. PubMed ID: 8642670
[TBL] [Abstract][Full Text] [Related]
2. The transmembrane domain of the E5 oncoprotein contains functionally discrete helical faces.
Adduci AJ; Schlegel R
J Biol Chem; 1999 Apr; 274(15):10249-58. PubMed ID: 10187811
[TBL] [Abstract][Full Text] [Related]
3. E5 oncoprotein retained in the endoplasmic reticulum/cis Golgi still induces PDGF receptor autophosphorylation but does not transform cells.
Sparkowski J; Anders J; Schlegel R
EMBO J; 1995 Jul; 14(13):3055-63. PubMed ID: 7621820
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous beta receptor for platelet-derived growth factor in mouse C127 cells.
Nilson LA; Gottlieb RL; Polack GW; DiMaio D
J Virol; 1995 Sep; 69(9):5869-74. PubMed ID: 7543592
[TBL] [Abstract][Full Text] [Related]
5. The bovine papillomavirus E5 protein requires a juxtamembrane negative charge for activation of the platelet-derived growth factor beta receptor and transformation of C127 cells.
Klein O; Kegler-Ebo D; Su J; Smith S; DiMaio D
J Virol; 1999 Apr; 73(4):3264-72. PubMed ID: 10074180
[TBL] [Abstract][Full Text] [Related]
6. Role of glutamine 17 of the bovine papillomavirus E5 protein in platelet-derived growth factor beta receptor activation and cell transformation.
Klein O; Polack GW; Surti T; Kegler-Ebo D; Smith SO; DiMaio D
J Virol; 1998 Nov; 72(11):8921-32. PubMed ID: 9765437
[TBL] [Abstract][Full Text] [Related]
7. Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein.
Petti LM; Reddy V; Smith SO; DiMaio D
J Virol; 1997 Oct; 71(10):7318-27. PubMed ID: 9311809
[TBL] [Abstract][Full Text] [Related]
8. Golgi alkalinization by the papillomavirus E5 oncoprotein.
Schapiro F; Sparkowski J; Adduci A; Suprynowicz F; Schlegel R; Grinstein S
J Cell Biol; 2000 Jan; 148(2):305-15. PubMed ID: 10648563
[TBL] [Abstract][Full Text] [Related]
9. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain.
Cohen BD; Goldstein DJ; Rutledge L; Vass WC; Lowy DR; Schlegel R; Schiller JT
J Virol; 1993 Sep; 67(9):5303-11. PubMed ID: 8394451
[TBL] [Abstract][Full Text] [Related]
10. E5 oncoprotein mutants activate phosphoinositide 3-kinase independently of platelet-derived growth factor receptor activation.
Suprynowicz FA; Sparkowski J; Baege A; Schlegel R
J Biol Chem; 2000 Feb; 275(7):5111-9. PubMed ID: 10671555
[TBL] [Abstract][Full Text] [Related]
11. A glutamine residue in the membrane-associating domain of the bovine papillomavirus type 1 E5 oncoprotein mediates its binding to a transmembrane component of the vacuolar H(+)-ATPase.
Goldstein DJ; Kulke R; Dimaio D; Schlegel R
J Virol; 1992 Jan; 66(1):405-13. PubMed ID: 1370089
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the beta-type platelet-derived growth factor receptor defines the site of interaction with the bovine papillomavirus type 1 E5 transforming protein.
Staebler A; Pierce JH; Brazinski S; Heidaran MA; Li W; Schlegel R; Goldstein DJ
J Virol; 1995 Oct; 69(10):6507-17. PubMed ID: 7666552
[TBL] [Abstract][Full Text] [Related]
13. The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions.
Goldstein DJ; Andresson T; Sparkowski JJ; Schlegel R
EMBO J; 1992 Dec; 11(13):4851-9. PubMed ID: 1334459
[TBL] [Abstract][Full Text] [Related]
14. Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling.
Drummond-Barbosa D; Vaillancourt RR; Kazlauskas A; DiMaio D
Mol Cell Biol; 1995 May; 15(5):2570-81. PubMed ID: 7739538
[TBL] [Abstract][Full Text] [Related]
15. Cellular transformation by a transmembrane peptide: structural requirements for the bovine papillomavirus E5 oncoprotein.
Meyer AN; Xu YF; Webster MK; Smith AE; Donoghue DJ
Proc Natl Acad Sci U S A; 1994 May; 91(11):4634-8. PubMed ID: 8197111
[TBL] [Abstract][Full Text] [Related]
16. Compensatory mutants of the bovine papillomavirus E5 protein and the platelet-derived growth factor β receptor reveal a complex direct transmembrane interaction.
Edwards AP; Xie Y; Bowers L; DiMaio D
J Virol; 2013 Oct; 87(20):10936-45. PubMed ID: 23926343
[TBL] [Abstract][Full Text] [Related]
17. c-Src activation by the E5 oncoprotein enables transformation independently of PDGF receptor activation.
Suprynowicz FA; Baege A; Sunitha I; Schlegel R
Oncogene; 2002 Mar; 21(11):1695-706. PubMed ID: 11896601
[TBL] [Abstract][Full Text] [Related]
18. The bovine papillomavirus type 1 E5 transforming protein specifically binds and activates the beta-type receptor for the platelet-derived growth factor but not other related tyrosine kinase-containing receptors to induce cellular transformation.
Goldstein DJ; Li W; Wang LM; Heidaran MA; Aaronson S; Shinn R; Schlegel R; Pierce JH
J Virol; 1994 Jul; 68(7):4432-41. PubMed ID: 8207816
[TBL] [Abstract][Full Text] [Related]
19. A single amino acid substitution converts a transmembrane protein activator of the platelet-derived growth factor β receptor into an inhibitor.
Petti LM; Talbert-Slagle K; Hochstrasser ML; DiMaio D
J Biol Chem; 2013 Sep; 288(38):27273-27286. PubMed ID: 23908351
[TBL] [Abstract][Full Text] [Related]
20. Specific interaction between the bovine papillomavirus E5 transforming protein and the beta receptor for platelet-derived growth factor in stably transformed and acutely transfected cells.
Petti L; DiMaio D
J Virol; 1994 Jun; 68(6):3582-92. PubMed ID: 8189497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
